Stocks · Healthcare · Medical - Specialties
Apyx Medical Corporation APYX
$2.55 +2.00% Close, Oct 2, 2026 · NASDAQ · Market cap $107.4M
Strong growth
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -6.1% from -26.5% a year earlier.
- Earnings beat analyst estimates in each of the last 8 quarters (average surprise over the last four: +34.0%).
- Revenue over the last four quarters was $58.4M, up 25.6% from a year earlier, accelerating from 18.2% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 27%
- Revenue growth, 3-year CAGRBottom 40%
- Revenue growth accelerationTop 15%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 40%
- Gross marginBottom 23%
- Operating marginTop 49%
- Accruals (lower is better)Bottom 13%
- Interest coverTop 45%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 50%
- Free-cash-flow yieldBottom 37%
- EBITDA / enterprise valueTop 41%
- Sales / enterprise valueTop 26%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 36%
- 6-month returnBottom 16%
- 1-year return vs S&P 500Top 45%
- Distance from 52-week highBottom 28%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 17%
- Consecutive EPS beatsTop 8%
- Share of analysts rating BuyTop 29%
- Upside to consensus price targetTop 25%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 31%
- Maximum drawdown, 3 yearsBottom 46%
- Beta vs S&P 500 (lower is better)Bottom 22%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 18.2% | 25.6% | ↑ |
| Gross margin | 61.6% | 33.9% | ↓ |
| Operating margin | -26.5% | -6.1% | ↑ |
| FCF margin | -21.6% | -18.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 25.6% | 18.2% | ↑ | Top 27% |
| Gross margin | 33.9% | 61.6% | ↓ | Bottom 23% |
| Operating margin | -6.1% | -26.5% | ↑ | Top 49% |
| Net margin | -14.8% | -37.1% | ↑ | — |
| Free-cash-flow margin | -18.9% | -21.6% | ↑ | — |
| Return on invested capital | -6.8% | — | Top 40% | |
| Revenue growth, 3-year CAGR | 5.9% | — | Bottom 40% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 2.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -4.6 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -8.97%
- Shareholder yield
- -8.97%
- Share count change, 1 year
- +3.5%
- Share count change, 3-year CAGR
- +6.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 8
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +34.0%
- Average 2-day reaction, last 8
- +5.2%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $6.50
- Target vs current price
- +154.9%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 89%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +14.6% | +0.5% | -27.8% | -25.6% | — |
| May 7, 2026 | +54.5% | +21.9% | +31.5% | +46.9% | +43.2% |
| Mar 10, 2026 | +50.0% | +0.6% | +7.0% | +9.3% | +10.5% |
| Nov 6, 2025 | +16.7% | +6.7% | +37.9% | +28.3% | +39.8% |
| Aug 7, 2025 | +3.6% | -3.9% | +15.2% | +0.5% | +44.6% |
| May 8, 2025 | +16.7% | -5.6% | +12.8% | +32.8% | +48.0% |
| Mar 13, 2025 | +7.7% | -2.8% | +1.9% | -15.9% | +56.1% |
| Nov 8, 2024 | +6.7% | +24.6% | +5.7% | +31.1% | +13.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.07 | -$0.08 | +14.6% | $13.9M |
| May 7, 2026 | -$0.05 | -$0.11 | +54.5% | $12.5M |
| Mar 10, 2026 | -$0.03 | -$0.06 | +50.0% | $19.2M |
| Nov 6, 2025 | -$0.05 | -$0.06 | +16.7% | $12.9M |
| Aug 7, 2025 | -$0.09 | -$0.09 | +3.6% | $11.4M |
| May 8, 2025 | -$0.10 | -$0.12 | +16.7% | $9.4M |
| Mar 13, 2025 | -$0.12 | -$0.13 | +7.7% | $14.2M |
| Nov 8, 2024 | -$0.14 | -$0.15 | +6.7% | $11.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2.04× | — | — | Top 26% |
| Free-cash-flow yield | -10.29% | — | — | Bottom 37% |
| Earnings yield | -8.11% | — | — | Bottom 50% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -15.2%
- 200-day average slope (20 days)
- -2.9%
- Distance from 50-day average
- -20.5%
- Distance from 200-day average
- -31.2%
- RSI (14)
- 35.3
- Relative volume
- 0.32×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 67.8%
- Volatility vs own 5-year history
- 16th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.75
- Correlation with S&P 500
- 0.32
- Current drawdown from 1-year high
- -47.5%
- Maximum drawdown, 3 years
- -73.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 22, 2021 | Apr 8, 2025 | -95.0% | 846 days | Not yet recovered |
| Mar 11, 2021 | Aug 2, 2021 | -25.6% | 99 days | 21 days (Aug 31, 2021) |
| Dec 8, 2020 | Dec 15, 2020 | -18.6% | 5 days | 20 days (Jan 14, 2021) |
| Jan 22, 2021 | Feb 1, 2021 | -17.2% | 6 days | 16 days (Feb 24, 2021) |
| Feb 24, 2021 | Mar 2, 2021 | -10.5% | 4 days | 7 days (Mar 11, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $107.4M
- EPS, diluted (TTM)
- -$0.21
- Revenue (TTM)
- $58.4M
- 52-week range
- $2.06 – $5.08
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $48.5M | $44.5M | $52.3M | $48.1M | $52.8M |
| Gross profit | $33.6M | $29.1M | $33.8M | $29.4M | $19.0M |
| Operating income | -$14.4M | -$23.6M | -$17.3M | -$18.8M | -$6.4M |
| Net income | -$15.2M | -$23.2M | -$18.7M | -$23.5M | -$11.2M |
| EPS (diluted) | -$0.44 | -$0.67 | -$0.54 | -$0.66 | -$0.27 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.5M | $14.2M | $9.4M | $11.4M | $12.9M | $19.2M | $12.5M | $13.9M |
| Net income | -$4.7M | -$4.6M | -$4.2M | -$3.8M | -$2.0M | -$1.3M | -$2.1M | -$3.2M |
| EPS (diluted) | -$0.14 | -$0.12 | -$0.12 | -$0.09 | -$0.05 | -$0.03 | -$0.05 | -$0.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$10.4M | -$20.3M | -$5.2M | -$18.0M | -$8.0M |
| Capital expenditure | -$723,000 | -$1.0M | -$533,000 | -$722,000 | -$1.1M |
| Free cash flow | -$11.2M | -$21.3M | -$5.8M | -$18.8M | -$9.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $67,000 | $365,000 | $2.7M | $7.0M | $9.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $27.6M
- Total assets
- $61.1M
- Total liabilities
- $50.0M
- Total debt
- $39.6M
- Net debt
- $12.0M
- Shareholders’ equity
- $10.7M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 218,049
- Days to cover
- 2.46
- Change vs previous report
- +6.3%
FINRA short interest, settlement date Sep 15, 2026.